文献速递神经核医学

重定位放射性示踪剂用于髓鞘成像:五种示踪剂头对头比较

Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-11-04

该研究在四只狒狒中头对头比较了18F-florbetaben、18F-florbetapir、18F-flutemetamol、11C-MeDAS和11C-PiB的脑动力学与白质结合。结果显示18F-florbetapir的SUVR最高,18F-florbetaben的BP最高,且18F-florbetapir与18F-florbetaben的DVR无差异但显著高于其他三种;作者认为两者是有前景的髓鞘成像示踪剂。

要点

  • 18F-florbetapir在白质中SUVR最高(1.38±0.03),其次为18F-flutemetamol、18F-florbetaben、11C-MeDAS和11C-PiB。
  • 18F-florbetaben的BP最高(0.32±0.06),高于18F-flutemetamol、11C-MeDAS和11C-PiB。
  • 18F-florbetapir与18F-florbetaben的DVR无差异,但均显著高于其他三种示踪剂。

核心结论

  • 18F-florbetapir和18F-florbetaben因结合较高且半衰期较长,是有前景的髓鞘成像示踪剂,可望用于脱髓鞘疾病的临床应用。

研究设计与样本

  • 研究纳入四只狒狒,每种放射性配体均进行90分钟动态PET扫描。
  • 除18F-florbetapir外,检查期间采集动脉血样以获得经放射性代谢物校正的输入函数。
  • 在白质中计算SUVR75-90、基于输入函数的Logan法BP以及以小脑灰质为参考区的Logan参考法DVR,并使用混合效应模型比较示踪剂间差异。

主要发现

  • 白质SUVR75-90:18F-florbetapir为1.38±0.03,18F-flutemetamol为1.34±0.02,18F-florbetaben为1.32±0.07,11C-MeDAS为1.27±0.04,11C-PiB为1.25±0.07。
  • BP:18F-florbetaben为0.32±0.06,18F-flutemetamol为0.20±0.03,11C-MeDAS为0.17±0.03,11C-PiB为0.16±0.03。
  • DVR:18F-florbetaben为1.26±0.06,18F-florbetapir为1.27±0.03,两者无差异但显著高于18F-flutemetamol(1.17±0.02)、11C-MeDAS(1.16±0.03)和11C-PiB(1.14±0.02)。

临床怎么用

  • 在需要髓鞘定量成像时,可优先考虑18F-florbetapir或18F-florbetaben,因其结合较高且18F半衰期较长便于临床使用。

局限性

  • 研究仅在四只狒狒中进行,样本量小,结果需在人类中进一步验证。
  • 18F-florbetapir未采集动脉血样,未获得其经放射性代谢物校正的输入函数及基于输入函数的BP。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Drugs promoting myelin repair represent a promising therapeutic approach in multiple sclerosis and several candidate molecules are currently being evaluated, fostering the need of a quantitative method to specifically measure myelin content in vivo. PET using the benzothiazole derivative 11C-PiB has been successfully used to quantify myelin content changes in humans. Stilbene derivatives, such as 11C-MeDAS, have also been shown to bind to myelin in animals and are considered a promising radiopharmaceutical class for myelin imaging. Fluorinated compounds from both classes are now commercially available and thus should constitute clinically useful myelin radiotracers. The aim of this study is to provide a head-to-head comparison of 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol, 11C-MeDAS, and 11C-PiB with regard to brain kinetics and binding in white matter (WM). METHODS: Four baboons underwent a 90-min dynamic PET scan for each radioligand. Arterial blood samples were collected during the exam for each radiotracer, except for 18F-florbetapir, to obtain a radiometabolite-corrected input function. Standardized uptake value ratio between 75 at 90 min (SUVR75-90), binding potential (BP) estimated with Logan method with input function, and distribution volume ratio (DVR) estimated with Logan reference method (using cerebellar gray matter as reference region) were calculated in WM and compared between tracers using mixed effect models. RESULTS: In WM, 18F-florbetapir had the highest SUVR75-90 (1.38 ± 0.03), followed by 18F-flutemetamol (1.34 ± 0.02), 18F-florbetaben (1.32 ± 0.07), 11C-MeDAS (1.27 ± 0.04), and 11C-PiB (1.25 ± 0.07). With regard to BP, 18F-florbetaben had the highest value (0.32 ± 0.06) compared with 18F-flutemetamol (0.20 ± 0.03), 11C-MeDAS (0.17 ± 0.03), and 11C-PiB (0.16 ± 0.03). No difference in DVR was detected between 18F-florbetaben (1.26 ± 0.06) and 18F-florbetapir (1.27 ± 0.03), but both were significantly higher in DVR than 18F-flutemetamol (1.17 ± 0.02), 11C-MeDAS (1.16 ± 0.03), and 11C-PiB (1.14 ± 0.02). CONCLUSIONS: Given their higher binding and longer half-life, our study indicates that 18F-florbetapir and 18F-florbetaben are promising tracers for myelin imaging which are readily available for clinical application in demyelinating diseases.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Auvity S, Tonietto M, Caillé F, et al. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB. Eur J Nucl Med Mol Imaging. 2019. PMID: 31686177. doi:10.1007/s00259-019-04516-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。